1 – 10 of 219
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease : a prospective cohort study
- Contribution to journal › Article
-
Mark
Identification of distinct and shared biomarker panels in different manifestations of cerebral small-vessel disease through proteomic profiling
- Contribution to journal › Article
-
Mark
Blood and CSF Biomarkers in Amyotrophic Lateral Sclerosis: Diagnostic and Prognostic Insights from a Systematic Review and Meta-analysis
(2026) AD/PD 2026
- Contribution to conference › Poster
-
Mark
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia
- Contribution to journal › Article
-
Mark
The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline
- Contribution to journal › Article
-
Mark
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers
- Contribution to journal › Article
-
Mark
Biological classification of memory clinic patients
- Contribution to journal › Article
-
Mark
Plasma phosphorylated tau217 discordance with amyloid status in an ethnically diverse mixed memory clinic cohort
- Contribution to journal › Article
- 2025
-
Mark
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum
- Contribution to journal › Article
-
Mark
Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid
(2025) In EMBO Molecular Medicine
- Contribution to journal › Article
